Annals of Oncology · 2010 · 79 citations · 22 references
MedicineCancer BiologyOncologyBreast OncologyCancer GeneticsMolecular OncologyHomologous RecombinationMetastatic Breast CancerRecombination EnzymesRecombination ProteinsRecombination RegulationSite-specific RecombinationAberrant RecombinationBrca MutationsCancer-associated Recombination DefectsHomologous Recombination DeficiencyHomologous Recombination Deficiency SignaturesHomologous Recombination ProteinNeoadjuvant Chemoradiotherapy
22
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from <i>BRCA</i> Mutation Carriers
Peter C.C. Fong, David S. Boss, Timothy A. Yap et al. · New England Journal of Medicine · 2009 · 3.6K citations · Full text
Medicine, Oncology, Pharmacology +17
Jos A. van der Hage, Cornelis J.�H. van de Velde, Jean‐Pierre Julien et al. · Journal of Clinical Oncology · 2001 · 1.1K citations
Medicine, Oncology, Breast Oncology +14
Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
Daniel P. Silver, Andrea L. Richardson, Aron C. Eklund et al. · Journal of Clinical Oncology · 2010 · 984 citations · Full text
Medicine, Oncology, Pharmacology +16
Sven Rottenberg, Janneke E. Jaspers, Ariena Kersbergen et al. · Proceedings of the National Academy of Sciences · 2008 · 949 citations · Full text
Medicine, Oncology, Pharmacology +16